Evolution of HLA‐sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Kevin Ferrari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France. Hauptthemen laut MEDLINE: Kidney Transplantation, Renal Insufficiency. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The optimal management of immunosuppressive therapy (IT) after kidney allograft failure (KAF) remains controversial. Although maintaining IT may reduce HLA‐sensitization and improve access to retransplantation, it may also increase the rate of immunosuppression‐related complications. The overall impact on patient mortality is unknown. The main objective of this study was to compare the evolution of HLA‐sensitization 6 months after KAF according to IT management.
Methods
Individual clinical and health care data were extracted from the French national end‐stage kidney disease registry (Renal Epidemiology and Information Network [REIN]) and the French National Health Data system (SNDS), respectively. Patients aged > 18 years returning to dialysis after KAF between January 2008 and December 2019 in Lorraine were included. Patients were classified into two groups, IT continuation or IT discontinuation. HLA‐sensitization was defined as an increase in incompatible graft rate (IGR) between KAF and 6 months post‐KAF (change to a higher predefined category (0%–5%), (5%–20%), (20%–50%), (50%–85%), (85%–95%), (95%–98%), (98%–100%)). Secondary outcome was patient survival according to IT management.
Results
A total of 121 patients were included, 35 (29%) of whom continued IT. HLA‐sensitization after KAF tended to be higher in the “IT discontinuation” group (57% vs. 38% in the “IT continuation” group, p = .07). In multivariate analysis, IT continuation was associated with a lower increase in IGR (OR .37, 95% CI [.14; .93]). IT management was not associated with patient mortality.
Conclusions
Continuation of IT after KAF was associated with less change in IGR and was not associated with excess mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Department, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
- Histocompatibility Laboratory, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
- IMoPA6, UMR7365 CNRS, Université de Lorraine, Vandoeuvre-les-Nancy, France.
- Clinical Epidemiology, Inserm CIC-EC, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
- Agence de la Biomédecine, Saint-Denis, France.
- Université de Lorraine, Inserm, Centre d'Investigation Clinique-1433, and Inserm U1116, CHRU Nancy, F-CRIN INI-CRCT, Nancy, France.
ORCID-Profile: Kevin Ferrari, Sophie Girerd
Zitieren
APA
Ferrari, K., Aarnink, A., Ayav, C., Frimat, L., Couchoud, C., Audry, B., Antoine, C., & Girerd, S. (2024). Evolution of HLA‐sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study. Clinical Transplantation. https://doi.org/10.1111/ctr.15160
Vancouver
Ferrari K, Aarnink A, Ayav C, Frimat L, Couchoud C, Audry B, et al. Evolution of HLA‐sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study. Clinical Transplantation. 2024. doi:10.1111/ctr.15160
BibTeX
@article{Ferrari2024,
author = {Ferrari, Kevin and Aarnink, Alice and Ayav, Carole and Frimat, Luc and Couchoud, Cécile and Audry, Benoît and Antoine, Corinne and Girerd, Sophie},
title = {Evolution of HLA‐sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15160}
}
EUVIMED